Alan Collier

Alan Collier Email and Phone Number

CEO at Endonovo Therapeutics, Inc. and SofPulse, Inc. @ Sofpulse
Alan Collier's Location
Los Angeles County, California, United States, United States
Alan Collier's Contact Details
About Alan Collier

Mr. Collier has over twenty years of experience in corporate finance, accounting and computer science.Specialties: Strategic planning; corporate formation; mergers and acquisitions; business development; business plan compilation; reverse mergers; equity and debt structure and financing; augmentation of management; capital restructuring; joint ventures; and procurement of channel partners.

Alan Collier's Current Company Details
Sofpulse

Sofpulse

View
CEO at Endonovo Therapeutics, Inc. and SofPulse, Inc.
Alan Collier Work Experience Details
  • Sofpulse
    Chief Executive Officer
    Sofpulse Jan 2023 - Present
    Woodland Hills, California, Us
    SofPulse, Inc. as a commercial developer and distributor in the medical device industry is in a unique position in the global healthcare market.SofPulse, Inc. has an FDA Clearance and is clinically proven for treating post-operative pain and edemawithout the use of harmful drugs! Moreover, we have ongoing clinical studies...We are currently launching into the VA/DOD market and providing our Veterans stream-linedlogistics and supply management with our goal to make SofPulse® the standard care for postoperativepain.Additionally, Sofpulse has received a TFDA in Taiwan, a pre-Market approval, August 2023, and has a Sales and Strategic Partnership Agreement with Evermed Medical Enterprise Ltd., a leading medical device distributor in Taiwan, ROC (Republic of China) to distribute SofPulse® medical devices in Taiwan.
  • Endonovo Therapeutics, Inc.
    Ceo
    Endonovo Therapeutics, Inc. Sep 2011 - Present
    Woodland Hills, Ca, Us
    Endonovo Therapeutics, Inc. (OTCQB: ENDV) is a biotechnology company developing non-invasive electromagnetic therapies designed to extend and enhance the human life by regenerating tissues and organs that have become injured or damaged by disease and age. Endonovo is developing therapies for various inflammatory, autoimmune and degenerative diseases using Time-Varying Electromagnetic Fields (TVEMF). The Company's business model includes the international licensing of its stem cell mobilization and expansion technologies and the development of non-invasive electromagnetic therapies.
  • Ip Resources International, Inc.
    Chief Executive Officer
    Ip Resources International, Inc. Sep 2011 - Present
    Woodland Hills, California, Us
    IP Resources International, Inc., a wholly owned subsidiary of Endonovo Therapeutics, Inc. (OTCQB: ENDV) acquires licenses to compelling technologies and products and commercializes them by forming joint ventures with international corporations and through sub-licensing on a territory-by-territory basis.Technologies are commercialized in the United States and territories including Brazil, Russia, India, China and the European Union. IP Resources' goal is to maximize the value of patents by fully commercializing them internationally and shortening the time to market for innovative technologies and products. IP Resources primarily targets market-ready technologies that have broad applications in international markets and have strong, defensible patents in healthcare, clean energy, internet and mobile devices.SpecialtiesLicensing, Joint Ventures, Distribution, Marketing
  • Mid-Market Securities, Llc
    Senior Managing Director
    Mid-Market Securities, Llc Jun 2010 - Jun 2013
    New York, New York, Us
    Mid-Market Securities, LLC is a FINRA/SIPC registered broker dealer providing large firm expertise and domestic and international processing capabilities to Public and Private companies and their owners in the middle market and to emerging growth, project finance and start-up clients; across a wide range of industries. Our services include Mergers & Acquisitions, Sales and Divestitures and Buy Side Advisory & Financing; Private Placements, Project Finance and Venture Capital Financing; Corporate Reorganization, Restructuring & Recapitalization; Joint Ventures, Strategic Relationships, Licensing and Royalty transactions; Valuation Analysis, Fairness Opinions and Expert Witness Testimony; and General Financial Advisory & Consulting Services; involving public and private companies, in the US and internationally; as well as Placement Agent Services for Alternative Investment Funds.
  • C2 Capital
    Managing Member
    C2 Capital Aug 2007 - Jun 2013
    C2 Capital is a business consulting firm based in Westlake Village, CA. C2 Capital assist: 1) early-stage companies in their business development and strategic direction; and 2) micro and small cap public companies in enhancing their value.
  • C2 Capital
    Managing Director
    C2 Capital May 2009 - Jun 2010
  • Corporate Capital Group, Llc
    Vice President
    Corporate Capital Group, Llc Sep 2008 - May 2009
    Corporate Capital Group (CCG) established in 1991, is a full service investment bank offering specialized corporate finance advisory services to high growth oriented middle market and select early-stage companies in both the public and the private space. While the Firm does not confine its focus to any specific industries, CCG does have substantial experience in the areas of aerospace, defense, information technology, health care, entertainment, transportation, manufacturing, and distribution and has completed transactions representing more than $2 billion.

Alan Collier Skills

Start Ups Private Placements Venture Capital Corporate Finance Valuation Investment Banking Mergers Restructuring Strategic Planning Business Strategy Joint Ventures Private Equity New Business Development Corporate Development Business Planning Finance Capital Securities Emerging Markets Alternative Investments Equities Financial Analysis Licensing Project Finance Ipo Contract Negotiation Product Development Business Analysis M&a Experience Financial Structuring Capital Raising Healthcare Organizational Development Telecommunications Wireless Deal Sourcing Reverse Mergers Bioscience Business Integration Corporate Governance Medical Devices Underwriting Web Development Growth Capital Lbo Intellectual Property Debt Restructuring Business Management Global Commercialization

Alan Collier Education Details

  • Arizona State University
    Arizona State University
  • California State University, Northridge
    California State University, Northridge

Frequently Asked Questions about Alan Collier

What company does Alan Collier work for?

Alan Collier works for Sofpulse

What is Alan Collier's role at the current company?

Alan Collier's current role is CEO at Endonovo Therapeutics, Inc. and SofPulse, Inc..

What is Alan Collier's email address?

Alan Collier's email address is ac****@****ovo.com

What is Alan Collier's direct phone number?

Alan Collier's direct phone number is +191928*****

What schools did Alan Collier attend?

Alan Collier attended Arizona State University, California State University, Northridge.

What skills is Alan Collier known for?

Alan Collier has skills like Start Ups, Private Placements, Venture Capital, Corporate Finance, Valuation, Investment Banking, Mergers, Restructuring, Strategic Planning, Business Strategy, Joint Ventures, Private Equity.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.